BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Research

Nouscom Reaches Clinical Phase II Using ProBioGen’s AGE1.CR.pIX® Production Platform

Nous-209 has been developed using the Nouscom's viral vector platform, which includes adenoviral and Modified Vaccinia Ankara (MVA) vectors, with MVA vecto...

May 04, 2023 | News

Revolutionizing Drug Development: IQVIA's David Cameron on the Power of Innovative Trial Designs

Can you tell us about your role as Senior Director & Global Head of Novel Trial Design at IQVIA? The Novel Trial Design initiative at IQ...

May 09, 2023 | News

The Impact of Digital Health Technologies in Oncology: Current State and Future Directions

Digital health has revolutionized the way healthcare is delivered and managed in recent years. Oncology is one field that has benefited significantly from ...

May 03, 2023 | Opinion

Cellenkos Doses First Patient with CK0803 Cell Therapy for ALS Treatment

Cellenkos® Inc., a clinical stage biotechnology company focused on developing allogeneic, off-the-shelf, T regulatory cell therapies for treatment...

May 03, 2023 | News

Melanoma Research Alliance awards $6.3M in grants for prevention, detection, and treatment

MRA-funded research spans the entire spectrum of the disease including melanoma prevention, diagnosis, treatment, and metastatic disease. Melanoma is the d...

May 02, 2023 | News

New Data Confirms Efficacy of ZIRCON Study in Imaging Kidney Cancer Masses Smaller Than 2cm at AUA

The results were featured in a late-breaking oral presentation delivered on Sunday, 30 April 2023 (CST) by Associate Professor Brian Shuch, ...

May 01, 2023 | News

HOYA elevates children's myopia and light protection with MiYOSMART Sun lenses.

Origins of MiYOSMART lenses Developed by HOYA Vision Care in cooperation with The Hong Kong Polytechnic University, MiYOSMART is a line of innovative opht...

April 30, 2023 | News

Merck Kicks Off 2023 Curiosity Cube Mobile Lab Tour

Over 250 events expected to reach more than 45,000 future scientists on two continents Hands-on experiments to focus on impact of contamination on the p...

April 30, 2023 | News

Singleron Biotechnologies joins ISS Collaboration for space research in pursuit of "Reaching for the Stars"

The MALETH Project, which was led by Professor Joseph Borg from the University of Malta brought internationally excelling scientists to...

April 30, 2023 | Company results

Healint announces collaboration with Saitama Medical University Hospital in Japan to verify AI diagnosis of migraine

Although there are currently 30 million chronic headache patients in Japan, the diagnosis and treatment rate of migraine among non-headache specialist...

April 28, 2023 | News

Agilent and Theragen Bio Partner to Advance Bioinformatic Solutions for Cancer Genomic Profiling in South Korea

Agilent Technologies Inc. (NYSE: A) announced the recent signing of a Memorandum of Understanding (MOU) with Theragen Bio in South Korea to ...

April 26, 2023 | News

Gene Solutions' multi-cancer early detection shows promise in Southeast Asia's biotech industry.

Circulating tumor DNA, or cell-free tumor DNA (ctDNA) assay is based on detecting the appearance of ctDNA in blood. This method is sometimes called Liquid ...

April 26, 2023 | News

I-Mab Doses First Patient in Phase 3 Study of Lemzoparlimab for MDS in China

The Phase 3 trial is a randomized, controlled, open-label, multi-center study to evaluate the efficacy and safety of lemzoparlimab in combination with AZA ...

April 25, 2023 | News

Excelra Acquires BISC Global, Forming International Bioinformatics Powerhouse

Excelra is a trusted partner to the world's top pharmaceutical and biotechnology companies, providing data, insight, and R&D technology services. Its i...

April 21, 2023 | News

Stay Connected